TETRALYSAL 300 ? – a product with pedigree from Galderma
Glymecycline 300mg – ONCE Daily, a convenient choice for today’s generation.
Tetralysal? is one of the few systemic products in the Galderma portfolio. It has gained a reputation in the acne market, in which two out of three patients are now treated with oral antibiotics. A member of the tetracycline family of antibiotics launched in the 1960’s, Tetralysal? has forged a solid reputation as a reliable, trouble-free treatment. Tetralysal? was launched recently with dermatologists in Malta offering a competitive solution in two of Galderma’s main therapeutic areas (acne and rosacea) as obvious complements to Differin? and Rozex? respectively.
Further Tetralysal? information from Collis Williams
Tel: 21 22 41 04, 21 24 48 47
adoloscence cancer cannabis Cardiology Contributions covid 19 dementia Dermatology Dermfest Diabetes Editorial endocrinology environmental health exercise Family Medicine Francesco Carelli gastroenterology Geriatrics gynaecology hypertension infections Infectious Diseases Medical Education Medicine and the arts microbionta Neurology Nutrition obesity obstetrics Oncology Orthopaedics Paediatrics Pharmacology Pharmacy Practice pregnancy Psychiatry Public Health Radiology Respiratory Medicine Rheumatology smoking Surgery TheSynapse Interview Urology Women's health